New injection tested in healthy people for future allergy and lung disease treatments
NCT ID NCT05803902
First seen Jan 05, 2026 · Last updated Jun 15, 2026 · Updated 33 times
Summary
This early-stage study tested the safety of an experimental injection called 9MW1911 in 48 healthy adults aged 18 to 65. The main goal was to see if the drug is safe and to find the highest dose people can tolerate without serious side effects. This study does not treat any disease but collects important information for future research on conditions like asthma, COPD, and eczema.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Hospital
Beijing, Beijing Municipality, 100000, China
Conditions
Explore the condition pages connected to this study.